Fitzpatrick M O, Goyal K, Barlow P
Department of Neurosurgery, Southern General Hospital NHS Trust, Glasgow.
Scott Med J. 1999 Apr;44(2):47-8. doi: 10.1177/003693309904400206.
In a previous paper on mortality audit we reported on the use of treatment limiting decisions (TLDs) in a neurosurgical unit in the year 1988. In this paper we compare the findings of a similar audit for 1997. It appears that our unit's policy of openly discussing all TLDs in patients who die had led to such decisions being made at a more appropriate stage in the patient's illness. Regular review of TLDs is probably helpful in increasing the confidence of clinicians to make these difficult decisions openly and timeously.
在之前一篇关于死亡率审计的论文中,我们报告了1988年在一个神经外科病房使用治疗限制决策(TLDs)的情况。在本文中,我们比较了1997年类似审计的结果。看来我们科室公开讨论所有死亡患者的治疗限制决策的政策,已促使这些决策在患者病程中更恰当的阶段做出。定期审查治疗限制决策可能有助于增强临床医生公开且及时做出这些艰难决策的信心。